Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology
Oxford Open Immunology · 14.03.2024 · 5 (1)
DOI: 10.1093/oxfimm/iqae010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oxford Open Immunology, online erschienen am 17.08.2024. Verfasst von Kar On Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWO-funded SBO project DeVEnIR, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Protective immunity to opportunistic fungal infections consists of tightly regulated innate and adaptive immune responses that clear the infection. Immune responses to infections of the vaginal mucosa by Candida species are, however, an exception. In the case of vulvovaginal candidiasis (VVC), the inflammatory response is associated with symptomatic disease, rather than that it results in pathogen clearance. As such VVC can be considered an inflammatory disease, which is a significant public health problem due to its predominance as a female-specific fungal infection. Particularly, women with recurrent VVC (RVVC) suffer from a significant negative impact on their quality of life and mental health. Knowledge of the inflammatory pathogenesis of (R)VVC may guide more effective diagnostic and therapeutic options to improve the quality of life of women with (R)VVC. Here, we review the immunopathogenesis of (R)VVC describing several elements that induce an inflammatory arson, starting with the activation threshold established by vaginal epithelial cells that prevent unnecessary ignition of inflammatory responses, epithelial and inflammasome-dependent immune responses. These inflammatory responses will drive neutrophil recruitment and dysfunctional neutrophil-mediated inflammation. We also review the, sometimes controversial, findings on the involvement of adaptive and systemic responses. Finally, we provide future perspectives on the potential of some unexplored cytokine axes and discuss whether VVC needs to be subdivided into subgroups to improve diagnosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (Leibniz-HKI), Beutenbergstraße 11a, Jena, 07749, Germany.
- Department of Medicine and Surgery, University of Perugia, Piazza Lucio Severi 1, Perugia, 06132, Italy.
ORCID-Profile: Kar On Cheng, Dolly E Montaño, Teresa Zelante, Axel Dietschmann, Mark S Gresnigt
Förderung
- FWO-funded SBO project DeVEnIR
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Cheng, K. O., Montaño, D. E., Zelante, T., Dietschmann, A., & Gresnigt, M. S. (2024). Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology. Oxford Open Immunology, 5(1). https://doi.org/10.1093/oxfimm/iqae010
Vancouver
Cheng KO, Montaño DE, Zelante T, Dietschmann A, Gresnigt MS. Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology. Oxford Open Immunology. 2024;5(1). doi:10.1093/oxfimm/iqae010
BibTeX
@article{Cheng2024,
author = {Cheng, Kar On and Montaño, Dolly E and Zelante, Teresa and Dietschmann, Axel and Gresnigt, Mark S},
title = {Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology},
journal = {Oxford Open Immunology},
year = {2024},
volume = {5},
number = {1},
doi = {10.1093/oxfimm/iqae010}
}
EUVIMED